ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2).

Trial Profile

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2).

Recruiting
Phase of Trial: Phase II/III

Latest Information Update: 24 Mar 2017

At a glance

  • Drugs Cisplatin (Primary) ; Doxorubicin (Primary) ; Ifosfamide (Primary) ; Methotrexate (Primary) ; Mifamurtide (Primary)
  • Indications Osteosarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Oct 2013 Planned end date changed from 1 Jul 2019 to 1 Feb 2020 as reported by ClinicalTrials.gov.
    • 05 Jan 2012 New source identified from European Clinical Trials Database.
    • 27 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top